Jeff Randall

Jeff Randall is the current Director of Assay Technologies at Quantum Diamond Technologies. Prior to this, they were a Senior Scientist at US Genomics from January 2002 to December 2007. In this role, they were responsible for identifying the option of developing life science applications for mRNA and microRNA detection as an added market resource while the significant challenges of rapid single molecule genomic mapping were worked out. Jeff also contributed to bringing commercial RNA detection and measurement to the commercial space.

During their time at US Genomics, they also managed the technical development, stability, and biological validation of the Trilogy 2020 instrument; provided technical writing, including user manuals, application notes, regulatory compliance, and intellectual property; installed and provided training for Trilogy 2020 platform at collaborator and customer sites; made technical presentations for scientific meetings, customers, academic collaborators, investors, scientific advisory board, and Board of Directors; directed and managed academic collaborations; provided technical support and customer service for collaborators and customers; performed assay development for single molecule immuno-assays, direct mRNA, and rare copy gene identification; and co-conceived, developed, validated and commercialized single molecule detection microRNA assays for every miRNA for use on the Trilogy 2020 platform. The success of this program initiated the technology to be bought by another company. Jeff also participated in the “buy out” evaluation and technology transfer of the instrument use and the assay development technology. In their role at US Genomics, they managed up to five scientists including BS, MS, and Ph.D.s.

Jeff Randall began their educational career by earning a Bachelor of Arts in biology/biological sciences from Ithaca College. Jeff then went on to earn a Doctor of Philosophy in cell, molecular and developmental biology from Tufts University's Sackler School for Biomedical Sciences.

Jeff Randall reports to John Pena, CEO, Board Member. They work with Seabron Adamson - Part-time CFO, Business Adviser, Colin Connolly - Director, Technology Development, and Tomasz Piech - Director, Software Engineering.